Skip to main content

Advertisement

Log in

Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Thrombocytopenia is a marked feature of chronic liver disease and cirrhosis. We tried to clarify whether an accumulation of platelets in the liver contributes to thrombocytopenia and liver fibrosis in chronic liver disease.

Methods

Thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (HCC) with hepatitis C virus infection were included. The locations of platelets and Kupffer cells and the expression of platelet-derived growth factor (PDGF) receptor-β and smooth muscle actin (SMA) were identified by immunohistochemistry. Perisinusoidal mesenchymal cells that express PDGF receptor-β and SMA were interpreted as transformed hepatic stellate cells (HSCs).

Results

Patients with cirrhosis had a more extensive platelet area in the liver compared to controls (5601 ± 5611 vs. 564 ± 361 μm2, p = 0.02), although the blood platelet count significantly decreased along with the progression of liver fibrosis. In cirrhotic liver, most platelets were present in the sinusoidal space of the periportal area with inflammation, where HSCs expressing PDGF receptor-β were frequently observed. In addition, the platelet and Kupffer cell areas were significantly smaller in cancerous tissue than those in noncancerous tissues (platelet area: 492 ± 823 vs. 3643 ± 4055 μm2, p = 0.001; Kupffer cell area: 450 ± 841 vs. 3012 ± 3051 μm2, p = 0.001).

Conclusions

The accumulation of platelets in the liver with chronic hepatitis may be involved in thrombocytopenia and liver fibrosis through the activation of HSCs. In addition, our findings also indicate that both platelets and Kupffer cells decrease in HCC tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res. 1997;46:4–18.

    Article  PubMed  CAS  Google Scholar 

  2. Handagama PJ, George JN, Shuman MA, McEver RP, Bainton DF. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA. 1987;84:861–5.

    Article  PubMed  CAS  Google Scholar 

  3. Verheul HMW, Hoekman K, Bakker SL, Eekman CA, Folman CC, Broxterman HJ, et al. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res. 1997;3:2187–90.

    PubMed  CAS  Google Scholar 

  4. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released. Blood. 2008;111:1227–33.

    Article  PubMed  CAS  Google Scholar 

  5. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005;67:30–8.

    Article  PubMed  CAS  Google Scholar 

  6. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005;113:752–60.

    Article  PubMed  CAS  Google Scholar 

  7. Gilsanz F, Escalante F, Auray C, Olbes AG. Treatment of leg ulcers in β-thalassaemia intermedia: use of platelet-derived wound healing factors from the patient’s own platelets. Br J Haematol. 2001;115:710.

    Article  PubMed  CAS  Google Scholar 

  8. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, et al. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion. 2004;44:1013–8.

    Article  PubMed  CAS  Google Scholar 

  9. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104–7.

    Article  PubMed  CAS  Google Scholar 

  10. Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol. 2002;3:425–30.

    Article  PubMed  CAS  Google Scholar 

  11. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood. 2004;104:397–401.

    Article  PubMed  CAS  Google Scholar 

  12. Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med. 2005;11:1167–9.

    Article  PubMed  CAS  Google Scholar 

  13. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med. 2008;14:756–61.

    Article  PubMed  CAS  Google Scholar 

  14. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–18.

    PubMed  CAS  Google Scholar 

  15. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38–53.

    Google Scholar 

  16. Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017–29.

    Article  PubMed  CAS  Google Scholar 

  17. Aoki Y, Hirai K, Tanikawa K. Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets. Eur J Nucl Med. 1993;20:123–9.

    Article  PubMed  CAS  Google Scholar 

  18. Schmidt KG, Rasmussen JW, Bekker C, Madsen PE. Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia. Scand J Haematol. 1985;34:39–46.

    Article  PubMed  CAS  Google Scholar 

  19. Toghill PJ, Green S. Splenic influences on the blood in chronic liver disease. Q J Med. 1979;48:613–25.

    PubMed  CAS  Google Scholar 

  20. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 1966;45:645–57.

    Article  PubMed  CAS  Google Scholar 

  21. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol. 2000;14:60D–6D.

    Google Scholar 

  22. Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, et al. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol. 2007;22:112–8.

    Article  PubMed  CAS  Google Scholar 

  23. Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22:1682–8.

    Article  PubMed  CAS  Google Scholar 

  24. Kinuya K, Matano S, Nakashima H, Taki S. Scintigraphic prediction of therapeutic outcomes of splenectomy in patients with thrombocytopenia. Ann Nucl Med. 2003;17:161–4.

    Article  PubMed  Google Scholar 

  25. Sata M, Yano Y, Yoshiyama Y, Ide T, Kumashiro R, Suzuki H, et al. Mechanism of thrombocytopenia induced by interferon therapy for chronic hepatitis B. J Gastroenterol. 1997;32:206–10.

    Article  PubMed  CAS  Google Scholar 

  26. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–20.

    Article  PubMed  CAS  Google Scholar 

  27. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409–17.

    Article  PubMed  CAS  Google Scholar 

  28. Hirohashi S, Blum HE, Ishak KG, Deugnier Y, Kojiro M, Laurent Puig P, et al. Tumours of the liver and intrahepatic bile ducts. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics of tumor of the digestive system. World Health Organization Classification of Tumors. Lyon: IARC Press; 2000. p. 159–72.

  29. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone C, Gentilini A, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol. 1996;148:785–800.

    PubMed  CAS  Google Scholar 

  30. Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 1991;5:271–7.

    PubMed  CAS  Google Scholar 

  31. Ikura Y, Morimoto H, Ogami M, Jomura H, Ikeoka N, Sakurai M. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol. 1997;32:496–501.

    Article  PubMed  CAS  Google Scholar 

  32. Hill-Zobel RL, McCandless B, Kang SA, Chikkappa G, Tsan MF. Organ distribution and fate of human platelets: studies of asplenic and splenomegalic patients. Am J Hematol. 1986;23:231–8.

    Article  PubMed  CAS  Google Scholar 

  33. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938–49.

    Article  PubMed  CAS  Google Scholar 

  34. Bussolino F, Camussi G, Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1α. J Biol Chem. 1988;263:11856–61.

    PubMed  CAS  Google Scholar 

  35. Miyazawa Y, Tsutsui H, Mizuhara H, Fujiwara H, Kaneda K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology. 1998;27:497–506.

    Article  PubMed  CAS  Google Scholar 

  36. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29.

    Article  PubMed  CAS  Google Scholar 

  37. Spengler U, Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin Sci. 2007;112:141–55.

    Article  PubMed  CAS  Google Scholar 

  38. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007;133:1627–36.

    Article  PubMed  CAS  Google Scholar 

  39. Pearson JM, Schultze AE, Jean PA, Roth RA. Platelet participation in liver injury from Gram-negative bacterial lipopolysaccharide in the rat. Shock. 1995;4:178–86.

    Article  PubMed  CAS  Google Scholar 

  40. Itoh H, Cicala C, Douglas GJ, Page CP. Platelet accumulation induced by bacterial endotoxin in rats. Thromb Res. 1996;83:405–19.

    Article  PubMed  CAS  Google Scholar 

  41. Nakamura M, Shibazaki M, Nitta Y, Endo Y. Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: the role of Kupffer cells. J Hepatol. 1998;28:991–9.

    Article  PubMed  CAS  Google Scholar 

  42. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989;84:1786–93.

    Article  PubMed  CAS  Google Scholar 

  43. Dirks RP, Bloemers HP. Signals controlling the expression of PDGF. Mol Biol Rep. 1996;22:1–24.

    Article  CAS  Google Scholar 

  44. Borkham-Kamphorst E, van Roeyen CRC, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol. 2007;46:1064–74.

    Article  PubMed  CAS  Google Scholar 

  45. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol. 2006;45:419–28.

    Article  PubMed  CAS  Google Scholar 

  46. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–69.

    Article  PubMed  CAS  Google Scholar 

  47. Maass T, Thieringer FR, Mann A, Longerich T, Schirmacher P, Strand D, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer. 2011;128:1259–68.

    Article  PubMed  CAS  Google Scholar 

  48. Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 2003;14:91–8.

    Article  PubMed  CAS  Google Scholar 

  49. Kelly JD, Haldeman BA, Grant FJ, Murray MJ, Seifert RA, Bowen-Pope DF, et al. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J Biol Chem. 1991;266:8987–92.

    PubMed  CAS  Google Scholar 

  50. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology. 1996;24:807–12.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reiichiro Kondo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kondo, R., Yano, H., Nakashima, O. et al. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol 48, 526–534 (2013). https://doi.org/10.1007/s00535-012-0656-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-012-0656-2

Keywords

Navigation